(Q48003083)

14 June 2018

title

Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas (English)

1 reference

14 June 2018

author name string

S Uchino

1

1 reference

14 June 2018

S Noguchi

2

1 reference

14 June 2018

M Adachi

3

1 reference

14 June 2018

M Sato

4

1 reference

14 June 2018

H Yamashita

5

1 reference

14 June 2018

S Watanabe

6

1 reference

14 June 2018

T Murakami

7

1 reference

14 June 2018

M Toda

8

1 reference

14 June 2018

N Murakami

9

1 reference

14 June 2018

H Yamashita

10

1 reference

14 June 2018

publication date

1 April 1998

1 reference

14 June 2018

number of pages

8

1 reference

Japanese Journal of Cancer Research

inferred from page(s)

published in

1 reference

14 June 2018

volume

89

1 reference

14 June 2018

issue

4

1 reference

14 June 2018

page(s)

411-418

1 reference

14 June 2018

Somatic in frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto-oncogene

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Antioncogenes and human cancer

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

RET gene and its implications for cancer

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Loss of heterozygosity on chromosomes 1 and 11 in sporadic pheochromocytomas

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Identification of FAP locus genes from chromosome 5q21

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Identification and characterization of the familial adenomatous polyposis coli gene

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Genetic basis of endocrine disease: multiple endocrine neoplasia type 2

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

A novel somatic mutation in the RET proto-oncogene in familial medullary thyroid carcinoma with a germline codon 768 mutation.

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5921821

Deletion of genes on chromosome 1 in endocrine neoplasia

14 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1349-7006.1998.TB00579.X

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence

21 January 2018

1 reference

12 December 2020

RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer

1 reference

12 December 2020

Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma

1 reference

12 December 2020

A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma

1 reference

12 December 2020

Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA

1 reference

12 December 2020

Progress in genetic screening of multiple endocrine neoplasia type 2A: is calcitonin testing obsolete?

1 reference

12 December 2020

Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2A

1 reference

12 December 2020

RET mutations in exons 13 and 14 of FMTC patients

1 reference

12 December 2020

Frequent loss of heterozygosity at the DCC locus in gastric cancer

1 reference

12 December 2020

RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC

1 reference

12 December 2020

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

1 reference

12 December 2020

Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas

1 reference

12 December 2020

Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers

1 reference

12 December 2020

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2

1 reference

12 December 2020

10.1111/J.1349-7006.1998.TB00579.X

Identifiers

DOI

1 reference

14 June 2018

PMC publication ID

5921821

1 reference

14 June 2018

PubMed publication ID

9617347

1 reference

14 June 2018